Maxon H R, Kreines K W, Goldsmith R E, Knowles H C
Arch Intern Med. 1975 Nov;135(11):1477-80.
In an attemp- to clarify the clinical importance of glucose intolerance associated with acute thyrotoxicosis, 22 patients had evaluations performed for glucose tolerance while thyrotoxic and at mean follow-up times of 8.8 months and 11.6 years after adequate antithyroid treatment. High incidences of glucose intolerance at long-term follow-up (32%) and of histories suggestive of diabetic diathesis (43%) support the hypothesis that there is an inherited relationship between diabetes mellitus and thyrotoxicosis and suggest that initial testing of all thyrotoxic patients for glucose intolerance is advisable. In addition, all thyrotoxic patients displaying diabetic glucose intolerance after a return to the euthyroid state should be considered to have permanent diabetes mellitus until proved otherwise.
为阐明与急性甲状腺毒症相关的糖耐量异常的临床重要性,对22例患者在甲状腺毒症期以及在充分抗甲状腺治疗后的平均随访时间8.8个月和11.6年时进行了糖耐量评估。长期随访时糖耐量异常的高发生率(32%)以及提示糖尿病素质的病史(43%)支持糖尿病与甲状腺毒症之间存在遗传关系这一假说,并表明对所有甲状腺毒症患者进行糖耐量异常的初始检测是可取的。此外,所有在恢复到甲状腺功能正常状态后出现糖尿病性糖耐量异常的甲状腺毒症患者,在未被证明相反情况之前,均应被视为患有永久性糖尿病。